Rifamycin action on RNA polymerase in antibiotictolerant Mycobacterium tuberculosis results in differentially detectable populations

Kohta Saito, Thulasi Warrier, Selin Somersan-Karakaya, Lina Kaminski, Jianjie Mi, Xiuju Jiang, Suna Park, Kristi Shigyo, Ben Gold, Julia Roberts, Elaina Weber, William R. Jacobs, Carl F. Nathan

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Mycobacterium tuberculosis (Mtb) encounters stresses during the pathogenesis and treatment of tuberculosis (TB) that can suppress replication of the bacteria and render them phenotypically tolerant to most available drugs. Where studied, the majority of Mtb in the sputum of most untreated subjects with active TB have been found to be nonreplicating by the criterion that they do not grow as colony-forming units (cfus) when plated on agar. However, these cells are viable because they grow when diluted in liquid media. A method for generating such "differentially detectable" (DD) Mtb in vitro would aid studies of the biology and drug susceptibility of this population, but lack of independent confirmation of reported methods has contributed to skepticism about their existence. Here, we identified confounding artifacts that, when avoided, allowed development of a reliable method of producing cultures of ≥90% DD Mtb in starved cells. We then characterized several drugs according to whether they contribute to the generation of DD Mtb or kill them. Of the agents tested, rifamycins led to DD Mtb generation, an effect lacking in a rifampin-resistant strain with a mutation in rpoB, which encodes the canonical rifampin target, the β subunit of RNA polymerase. In contrast, thioridazine did not generate DD Mtb from starved cells but killed those generated by rifampin.

Original languageEnglish (US)
Pages (from-to)E4832-E4840
JournalProceedings of the National Academy of Sciences of the United States of America
Volume114
Issue number24
DOIs
StatePublished - Jun 13 2017

Fingerprint

DNA-Directed RNA Polymerases
Mycobacterium tuberculosis
Population
Rifampin
Tuberculosis
Rifamycins
Pharmaceutical Preparations
Thioridazine
Cohort Effect
rifamycin SV
Sputum
Artifacts
Agar
Stem Cells
Bacteria
Mutation

Keywords

  • Differentially detectable
  • Mycobacterium tuberculosis
  • Phenotypic tolerance
  • Rifampin
  • Thioridazine

ASJC Scopus subject areas

  • General

Cite this

Rifamycin action on RNA polymerase in antibiotictolerant Mycobacterium tuberculosis results in differentially detectable populations. / Saito, Kohta; Warrier, Thulasi; Somersan-Karakaya, Selin; Kaminski, Lina; Mi, Jianjie; Jiang, Xiuju; Park, Suna; Shigyo, Kristi; Gold, Ben; Roberts, Julia; Weber, Elaina; Jacobs, William R.; Nathan, Carl F.

In: Proceedings of the National Academy of Sciences of the United States of America, Vol. 114, No. 24, 13.06.2017, p. E4832-E4840.

Research output: Contribution to journalArticle

Saito, K, Warrier, T, Somersan-Karakaya, S, Kaminski, L, Mi, J, Jiang, X, Park, S, Shigyo, K, Gold, B, Roberts, J, Weber, E, Jacobs, WR & Nathan, CF 2017, 'Rifamycin action on RNA polymerase in antibiotictolerant Mycobacterium tuberculosis results in differentially detectable populations', Proceedings of the National Academy of Sciences of the United States of America, vol. 114, no. 24, pp. E4832-E4840. https://doi.org/10.1073/pnas.1705385114
Saito, Kohta ; Warrier, Thulasi ; Somersan-Karakaya, Selin ; Kaminski, Lina ; Mi, Jianjie ; Jiang, Xiuju ; Park, Suna ; Shigyo, Kristi ; Gold, Ben ; Roberts, Julia ; Weber, Elaina ; Jacobs, William R. ; Nathan, Carl F. / Rifamycin action on RNA polymerase in antibiotictolerant Mycobacterium tuberculosis results in differentially detectable populations. In: Proceedings of the National Academy of Sciences of the United States of America. 2017 ; Vol. 114, No. 24. pp. E4832-E4840.
@article{03c295e584d845a1be79a722c65279c5,
title = "Rifamycin action on RNA polymerase in antibiotictolerant Mycobacterium tuberculosis results in differentially detectable populations",
abstract = "Mycobacterium tuberculosis (Mtb) encounters stresses during the pathogenesis and treatment of tuberculosis (TB) that can suppress replication of the bacteria and render them phenotypically tolerant to most available drugs. Where studied, the majority of Mtb in the sputum of most untreated subjects with active TB have been found to be nonreplicating by the criterion that they do not grow as colony-forming units (cfus) when plated on agar. However, these cells are viable because they grow when diluted in liquid media. A method for generating such {"}differentially detectable{"} (DD) Mtb in vitro would aid studies of the biology and drug susceptibility of this population, but lack of independent confirmation of reported methods has contributed to skepticism about their existence. Here, we identified confounding artifacts that, when avoided, allowed development of a reliable method of producing cultures of ≥90{\%} DD Mtb in starved cells. We then characterized several drugs according to whether they contribute to the generation of DD Mtb or kill them. Of the agents tested, rifamycins led to DD Mtb generation, an effect lacking in a rifampin-resistant strain with a mutation in rpoB, which encodes the canonical rifampin target, the β subunit of RNA polymerase. In contrast, thioridazine did not generate DD Mtb from starved cells but killed those generated by rifampin.",
keywords = "Differentially detectable, Mycobacterium tuberculosis, Phenotypic tolerance, Rifampin, Thioridazine",
author = "Kohta Saito and Thulasi Warrier and Selin Somersan-Karakaya and Lina Kaminski and Jianjie Mi and Xiuju Jiang and Suna Park and Kristi Shigyo and Ben Gold and Julia Roberts and Elaina Weber and Jacobs, {William R.} and Nathan, {Carl F.}",
year = "2017",
month = "6",
day = "13",
doi = "10.1073/pnas.1705385114",
language = "English (US)",
volume = "114",
pages = "E4832--E4840",
journal = "Proceedings of the National Academy of Sciences of the United States of America",
issn = "0027-8424",
number = "24",

}

TY - JOUR

T1 - Rifamycin action on RNA polymerase in antibiotictolerant Mycobacterium tuberculosis results in differentially detectable populations

AU - Saito, Kohta

AU - Warrier, Thulasi

AU - Somersan-Karakaya, Selin

AU - Kaminski, Lina

AU - Mi, Jianjie

AU - Jiang, Xiuju

AU - Park, Suna

AU - Shigyo, Kristi

AU - Gold, Ben

AU - Roberts, Julia

AU - Weber, Elaina

AU - Jacobs, William R.

AU - Nathan, Carl F.

PY - 2017/6/13

Y1 - 2017/6/13

N2 - Mycobacterium tuberculosis (Mtb) encounters stresses during the pathogenesis and treatment of tuberculosis (TB) that can suppress replication of the bacteria and render them phenotypically tolerant to most available drugs. Where studied, the majority of Mtb in the sputum of most untreated subjects with active TB have been found to be nonreplicating by the criterion that they do not grow as colony-forming units (cfus) when plated on agar. However, these cells are viable because they grow when diluted in liquid media. A method for generating such "differentially detectable" (DD) Mtb in vitro would aid studies of the biology and drug susceptibility of this population, but lack of independent confirmation of reported methods has contributed to skepticism about their existence. Here, we identified confounding artifacts that, when avoided, allowed development of a reliable method of producing cultures of ≥90% DD Mtb in starved cells. We then characterized several drugs according to whether they contribute to the generation of DD Mtb or kill them. Of the agents tested, rifamycins led to DD Mtb generation, an effect lacking in a rifampin-resistant strain with a mutation in rpoB, which encodes the canonical rifampin target, the β subunit of RNA polymerase. In contrast, thioridazine did not generate DD Mtb from starved cells but killed those generated by rifampin.

AB - Mycobacterium tuberculosis (Mtb) encounters stresses during the pathogenesis and treatment of tuberculosis (TB) that can suppress replication of the bacteria and render them phenotypically tolerant to most available drugs. Where studied, the majority of Mtb in the sputum of most untreated subjects with active TB have been found to be nonreplicating by the criterion that they do not grow as colony-forming units (cfus) when plated on agar. However, these cells are viable because they grow when diluted in liquid media. A method for generating such "differentially detectable" (DD) Mtb in vitro would aid studies of the biology and drug susceptibility of this population, but lack of independent confirmation of reported methods has contributed to skepticism about their existence. Here, we identified confounding artifacts that, when avoided, allowed development of a reliable method of producing cultures of ≥90% DD Mtb in starved cells. We then characterized several drugs according to whether they contribute to the generation of DD Mtb or kill them. Of the agents tested, rifamycins led to DD Mtb generation, an effect lacking in a rifampin-resistant strain with a mutation in rpoB, which encodes the canonical rifampin target, the β subunit of RNA polymerase. In contrast, thioridazine did not generate DD Mtb from starved cells but killed those generated by rifampin.

KW - Differentially detectable

KW - Mycobacterium tuberculosis

KW - Phenotypic tolerance

KW - Rifampin

KW - Thioridazine

UR - http://www.scopus.com/inward/record.url?scp=85020710199&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85020710199&partnerID=8YFLogxK

U2 - 10.1073/pnas.1705385114

DO - 10.1073/pnas.1705385114

M3 - Article

C2 - 28559332

AN - SCOPUS:85020710199

VL - 114

SP - E4832-E4840

JO - Proceedings of the National Academy of Sciences of the United States of America

JF - Proceedings of the National Academy of Sciences of the United States of America

SN - 0027-8424

IS - 24

ER -